• Ownership

John W. Smither - Insider Trading & Ownership

Entity
Individual
Location
C/O Kythera Biopharmaceuticals, Inc., 27200 West Agoura Road, Suite 200, Calabasas, CA
Summary
The estimated net worth of John W. Smither is at least $830K dollars as of January 8, 2025. John W. Smither is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $541K. John W. Smither is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $178K. John W. Smither is the Director of GENELUX Corp and owns shares of GENELUX Corp (GNLX) stock worth about $112K.
All Insider Reports
All Insider Reports

Ownership of John W. Smither

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer $541K Feb 13, 2024
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $178K Jan 6, 2025
GNLX GENELUX Corp Director $112K Aug 1, 2024
AMTI Applied Molecular Transport Inc. Director Dec 27, 2023
EFTR, EFTRW eFFECTOR Therapeutics, Inc. Director Jun 22, 2023

Insider Transactions Reported by John W. Smither:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.